Key result
Higher TyG-BMI index linked to ~13% greater ischemic cardiomyopathy risk per unit.
Why the study?
The TG/HDL-C ratio and TyG-BMI index reliably indicate insulin resistance, but their association with ischemic cardiomyopathy and utility in risk prediction remained to be investigated.
Do insulin resistance markers (TyG-BMI and TG/HDL-C) and machine learning models accurately predict the risk of ischemic cardiomyopathy?
Case-Control (n=1,603)
No
Do insulin resistance markers (TyG-BMI and TG/HDL-C) and machine learning models accurately predict the risk of ischemic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Observational study reveals insulin resistance markers independently predict ischemic cardiomyopathy risk in adults, highlighting the value of machine learning tools.
BACKGROUND: The triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio and triglyceride glucose-body mass (TyG-BMI) index are reliable indicators of insulin resistance (IR). This study investigated their association with ischemic cardiomyopathy (ICM) and developed a machine learning-based model for ICM risk prediction. METHODS: In total, 1,603 subjects participated in this study. Univariable logistic regression analysis was conducted, and variables with P < 0.05 were selected for multivariable logistic regression to identify independent risk factors for ICM. Variables meeting this criterion were adopted to create eight machine learning models, from which the optimal model was selected. Using this best-performing model, SHAP values were visualized, and an online calculator was developed. The model was validated via a calibration plot and DCA. RESULTS: Univariate and multivariate logistic regression analyses revealed that TyG-BMI, age, ejection fraction, TC/HDL-C, sex, HDL-C, TC, BMI, hemoglobin, diabetes, and hypertension were independent risk factors for ICM (P < 0.05). Based on these factors, SHAP visualization and an online calculator were developed. The calibration plot indicated strong alignment between the model's predicted and actual values, whereas the DCA demonstrated the model's clinical utility. CONCLUSION: The TyG-BMI and TC/HDL-C ratio independently predict ICM risk, with the XGB model identified as the most effective for ICM risk prediction, indicating substantial clinical applicability. CLINICAL TRIAL REGISTRATION NUMBER: Not applicable.
No takes yet. Share an insight, caveat, or question.
Naman et al. (2026) conducted a case-control in Ischemic cardiomyopathy (n=1,603). TyG-BMI index and TC/HDL-C ratio vs. Lower levels of TyG-BMI and TC/HDL-C was evaluated on Ischemic cardiomyopathy (OR 1.13, 95% CI 1.10-1.16, p=<0.001). The TyG-BMI index and TC/HDL-C ratio independently predicted ischemic cardiomyopathy risk, with every one-unit increase in TyG-BMI associated with a 1.13-fold increased risk (OR 1.13).
Synapse has enriched 10 related papers. Consider them for comparative context: